“I wish to remain HIV negative”: Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya
Open Access
- 19 January 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (1), e0244226
- https://doi.org/10.1371/journal.pone.0244226
Abstract
Transgender women (TGW) and men who have sex with men (MSM) in sub-Saharan Africa have high HIV acquisition risks and can benefit from daily pre-exposure prophylaxis (PrEP). We assessed PrEP adherence by measuring tenofovir-diphosphate (TFV-DP) levels and explore motives for PrEP persistence in TGW and MSM. Participants were enrolled in a one-year PrEP programme and made quarterly visits irrespective of whether they were still using PrEP. At their month 6 visit, participants provided a dried blood spot to test for TFV-DP levels; protective levels were defined as those compatible with ≥4 pills per week (700–1249 fmol/punch). Before TFV-DP levels were available, a sub-set of these participants were invited for an in-depth interview (IDI). Semi-structured IDI topic guides were used to explore motives to uptake, adhere to, and discontinue PrEP. IDI data were analyzed thematically. Fifty-three participants (42 MSM and 11 TGW) were enrolled. At month 6, 11 (20.7%) participants (8 MSM and 3 TGW) were lost to follow up or stopped taking PrEP. Any TFV-DP was detected in 62.5% (5/8) of TGW vs. 14.7% of MSM (5/34, p = 0.01). Protective levels were detected in 37.5% of TGW (3/8), but not in any MSM. Nineteen IDI were conducted with 7 TGW and 9 MSM on PrEP, and 1 TGW and 2 MSM off PrEP. Unplanned or frequent risky sexual risk behaviour were the main motives for PrEP uptake. Among participants on PrEP, TGW had a more complete understanding of the benefits of PrEP. Inconsistent PrEP use was attributed to situational factors. Motives to discontinue PrEP included negative reactions from partners and stigmatizing healthcare services. While MSM evinced greater adherence challenges in this PrEP programme, almost 40% of TGW were protected by PrEP. Given high HIV incidences in TGW these findings hold promise for TGW PrEP programming in the region.Funding Information
- Sub-Saharan African Network for TB/HIV-1 Research Excellence (grant # DEL-15-006)
This publication has 30 references indexed in Scilit:
- Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort studyThe Lancet Infectious Diseases, 2014
- Barriers and Facilitators to Engagement and Retention in Care among Transgender Women Living with Human Immunodeficiency VirusAnnals of Behavioral Medicine, 2013
- Worldwide burden of HIV in transgender women: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2013
- Tenofovir, Emtricitabine, and Tenofovir Diphosphate in Dried Blood Spots for Determining Recent and Cumulative Drug ExposureAIDS Research and Human Retroviruses, 2013
- High Acceptability of HIV Pre-exposure Prophylaxis but Challenges in Adherence and Use: Qualitative Insights from a Phase I Trial of Intermittent and Daily PrEP in At-Risk Populations in KenyaAIDS and Behavior, 2012
- Transgender in Africa: Invisible, inaccessible, or ignored?SAHARA-J: Journal of Social Aspects of HIV/AIDS, 2012
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and WomenThe New England Journal of Medicine, 2012
- Hormone-treated transsexuals report less social distress, anxiety and depressionPsychoneuroendocrinology, 2012
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006
- The Social Epidemiology of Human Immunodeficiency Virus/Acquired Immunodeficiency SyndromeEpidemiologic Reviews, 2004